WHRY and Elevate Expand Help for Women and Families in Need
Recognizing the urgent need to ensure the health of women in our communities, Women’s Health Research at Yale and Elevate, the university’s health policy lab, are collaborating to deploy interventions grounded in the latest and most reliable research directly to women and families.
Using Behavioral Science and Economics to Help Women and Families Rise from Poverty
Women’s Health Research at Yale, Elevate, and The Tobin Center for Economic Policy at Yale, are working to meet the urgent health needs of under-resourced and overburdened pregnant and parenting women, harnessing the science of sex and gender for policy change that can overcome the potentially devastating impact of economic inequality on women’s health.
Yale Launches New Policy Lab to Elevate Mental Health and Disrupt Poverty
Elevate is a new policy laboratory stemming from the successful work of the Mental health Outreach for MotherS (MOMS) Partnership and joining forces with Women’s Health Research at Yale (WHRY) to apply science to the creation and spread of evidence-based interventions for socially and economically disadvantaged families in partnership with government agencies.Source: YaleNews
Pilot grants to study the health of women and resources for women faculty at Yale gaining momentum
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) --- are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
Sex-specific Immune Response in COVID-19 Linked to Cellular Metabolism
Researchers studying COVID-19 patients have found a metabolic pathway that is highly correlated with immune responses only in male patients, a group known to be more likely to suffer severe cases and die of the disease, representing a potential target for therapeutic intervention.Source: Yale News
In Female Veterans With Early ASCVD, Secondary Prevention Falls Short
Female veterans with premature atherosclerotic cardiovascular disease (ASCVD), as well as those with extremely premature disease onset, are much less likely to receive evidence-based medical therapy, including high-intensity statins, when compared with male veterans, a new Veterans Affairs (VA) study shows.Source: TCTMD